69 related articles for article (PubMed ID: 2530804)
1. The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals.
Lips P; Asscheman H; Uitewaal P; Netelenbos JC; Gooren L
J Bone Miner Res; 1989 Oct; 4(5):657-62. PubMed ID: 2530804
[TBL] [Abstract][Full Text] [Related]
2. The effect of androgen treatment on bone metabolism in female-to-male transsexuals.
Lips P; van Kesteren PJ; Asscheman H; Gooren LJ
J Bone Miner Res; 1996 Nov; 11(11):1769-73. PubMed ID: 8915785
[TBL] [Abstract][Full Text] [Related]
3. The effect of cyproterone acetate alone and in combination with ethinylestradiol on the hypothalamic pituitary adrenal axis, prolactin and growth hormone release in male-to-female transsexuals.
de Vries CP; Gooren LJ; van der Veen EA
Horm Metab Res; 1986 Mar; 18(3):203-5. PubMed ID: 2939014
[TBL] [Abstract][Full Text] [Related]
4. [Bone histology in postmenopausal osteoporosis--variations in cellular activity].
Lozo P; Krpan D; Krvavica A; Vukelić Baturić T; Fistonić I; Kusec V
Acta Med Croatica; 2004; 58(1):5-11. PubMed ID: 15125387
[TBL] [Abstract][Full Text] [Related]
5. Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist.
Dittrich R; Binder H; Cupisti S; Hoffmann I; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):586-92. PubMed ID: 16320157
[TBL] [Abstract][Full Text] [Related]
6. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.
Asscheman H; Giltay EJ; Megens JA; de Ronde WP; van Trotsenburg MA; Gooren LJ
Eur J Endocrinol; 2011 Apr; 164(4):635-42. PubMed ID: 21266549
[TBL] [Abstract][Full Text] [Related]
7. Effects of sex steroids on the neurotransmitter-specific aromatic amino acids phenylalanine, tyrosine, and tryptophan in transsexual subjects.
Giltay EJ; Bunck MC; Gooren LJ; Zitman FG; Diamant M; Teerlink T
Neuroendocrinology; 2008; 88(2):103-10. PubMed ID: 18511863
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol ester metabolism in plasma during estrogen and antiandrogen treatment in men with carcinoma of the prostate.
Wallentin L; Varenhorst E
J Lab Clin Med; 1981 Dec; 98(6):906-16. PubMed ID: 6458644
[TBL] [Abstract][Full Text] [Related]
9. Dramatic suppression of plasma and urinary prostate specific antigen and human glandular kallikrein by antiandrogens in male-to-female transsexuals.
Obiezu CV; Giltay EJ; Magklara A; Scorilas A; Gooren L; Yu H; Diamandis EP
J Urol; 2000 Mar; 163(3):802-5. PubMed ID: 10687981
[TBL] [Abstract][Full Text] [Related]
10. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
Marslew U; Overgaard K; Riis BJ; Christiansen C
Obstet Gynecol; 1992 Feb; 79(2):202-10. PubMed ID: 1309944
[TBL] [Abstract][Full Text] [Related]
11. The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects.
Giltay EJ; Kho KH; Blansjaar BA; Verbeek MM; Geurtz PB; Geleijnse JM; Gooren LJ
J Endocrinol; 2005 Oct; 187(1):109-16. PubMed ID: 16214946
[TBL] [Abstract][Full Text] [Related]
12. Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study.
Ruetsche AG; Kneubuehl R; Birkhaeuser MH; Lippuner K
Osteoporos Int; 2005 Jul; 16(7):791-8. PubMed ID: 15502960
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.
Gooren LJ; Giltay EJ; Bunck MC
J Clin Endocrinol Metab; 2008 Jan; 93(1):19-25. PubMed ID: 17986639
[TBL] [Abstract][Full Text] [Related]
14. Effects of a cyproterone-containing oral contraceptive on hormonal levels in polycystic ovarian disease.
Calaf-Alsina J; Rodriguez-Espinosa J; Cabero-Roura A; Lenti-Paoli O; Mora-Brugues J; Esteban-Altirriba J
Obstet Gynecol; 1987 Feb; 69(2):255-8. PubMed ID: 2949170
[TBL] [Abstract][Full Text] [Related]
15. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females.
Giltay EJ; Hoogeveen EK; Elbers JM; Gooren LJ; Asscheman H; Stehouwer CD
J Clin Endocrinol Metab; 1998 Feb; 83(2):550-3. PubMed ID: 9467573
[TBL] [Abstract][Full Text] [Related]
16. Estrogen treatment effects on cognition, memory and mood in male-to-female transsexuals.
Miles C; Green R; Hines M
Horm Behav; 2006 Dec; 50(5):708-17. PubMed ID: 16884726
[TBL] [Abstract][Full Text] [Related]
17. Effects of hormonal contraception on bone mineral density after 24 months of use.
Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
[TBL] [Abstract][Full Text] [Related]
18. Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals.
Slabbekoorn D; van Goozen SH; Megens J; Gooren LJ; Cohen-Kettenis PT
Psychoneuroendocrinology; 1999 May; 24(4):423-47. PubMed ID: 10341369
[TBL] [Abstract][Full Text] [Related]
19. Effect of a new oral antiandrogen-estrogen combination on the endometrium: histological and ultrastructural scanning electron microscopy study.
Fedele L; Cavalli G; Marchini M; Carinelli S; Candiani GB
Acta Eur Fertil; 1986; 17(1):9-13. PubMed ID: 3727896
[TBL] [Abstract][Full Text] [Related]
20. Histomorphometric analysis of normal bone from the iliac crest of Norwegian subjects.
Dahl E; Nordal KP; Halse J; Attramadal A
Bone Miner; 1988 Mar; 3(4):369-77. PubMed ID: 3228618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
